NCT05710315 - Evaluating the Utility of RELiZORB™ for Treating Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 7, 2025

Primary Completion Date

March 2, 2026

Study Completion Date

March 2, 2026

Conditions

Multi Organ FailureExocrine Pancreatic Insufficiency

Interventions

DEVICE

RELiZORB™

RELiZORB cartridges will be used with routine enteral feedings for 5 days for randomized participants

OTHER

Placebo

Placebo cartridges will be used with routine enteral feedings for 5 days for randomized participants

Trial Locations (1)

RECRUITING

Inova Fairfax Medical Campus, Falls Church